eTheRNA Manufacturing, a specialist CDMO member of the Belgian eTheRNA group, is introducing a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and ...

In this forward-looking whitepaper, Blue Mountain explores how agentic AI —autonomous, context-aware AI agents—could ...

Formulation Development Outsourcing Market · GlobeNewswire Inc. Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Pharma Formulation Development Outsourcing Market Size and Growth Trends and Companies ...

The funding round was led by Spero Ventures with participation from MBX Capital, Shimadzu Future Innovation Fund managed by Global Brain Corporation, Eli Lilly & Company, SignalFire, Ford Street ...

Particle Works is making major contributions to the field of nanomedicine by producing game-changing automated microfluidic systems with the potential to improve efficiency in the nanotherapeutic drug ...

CRDMOs offer a continuum of services from early discovery to clinical manufacturing, addressing solubility and stability challenges in NCE development. Advanced technologies like spray drying and ...

Clinical evaluation of several modified release once-daily formulations of danuglipron resulted in encouraging pharmacokinetic data for several candidates with one showing the most favorable profile ...

Scientists have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine learning algorithms to accelerate drug ...

Hyderabad, India, July 1, 2015: Asia's leading Discovery Research and Development organization, GVK BIO, announced the extended collaboration with Melbourne, Australia based clinical stage ...

The global formulation development outsourcing market is on a significant growth trajectory, with a projected compound annual growth rate (CAGR) of 7.2% over the next decade. Valued at USD 33.23 ...